Cargando…
Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs
MGH2.1 is a herpes simplex virus type 1 (HSV1) oncolytic virus that expresses two prodrug-activating transgenes: the cyclophosphamide (CPA)-activating cytochrome P4502B1 (CYP2B1) and the CPT11-activating secreted human intestinal carboxylesterase (shiCE). Toxicology and biodistribution of MGH2.1 in...
Autores principales: | Kasai, Kazue, Nakashima, Hiroshi, Liu, Fang, Kerr, Samantha, Wang, Jiang, Phelps, Mitch, Potter, Philip M, Goins, William B, Fernandez, Soledad A, Chiocca, E Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759737/ https://www.ncbi.nlm.nih.gov/pubmed/23922029 http://dx.doi.org/10.1038/mtna.2013.38 |
Ejemplares similares
-
Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene
por: Chiocca, E. Antonio, et al.
Publicado: (2020) -
Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018) -
Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021) -
Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
por: Dehelean, Cristina Adriana, et al.
Publicado: (2022) -
Prodrugs for Amines
por: Simplício, Ana L., et al.
Publicado: (2008)